SCHEDULE 13G/A: Laurence W. Lytton Discloses 2.6% Passive Stake in NeuroOne Medical Technologies Corp.
Beneficial Ownership Disclosure
Laurence W. Lytton has filed an amended Schedule 13G, disclosing a 2.6% beneficial ownership stake in NeuroOne Medical Technologies Corp., held for passive investment purposes.
Summary
- Laurence W. Lytton beneficially owns an aggregate of 1,295,288 shares of NeuroOne Medical Technologies Corp. Common Stock.
- This ownership represents 2.6% of the company's outstanding Common Stock.
- The beneficial ownership consists of 1,086,954 shares of Common Stock and warrants to purchase 208,334 shares of Common Stock.
- The warrants are subject to a 9.99% beneficial ownership limitation.
- The percentage of class is calculated based on 49,817,835 shares of Common Stock outstanding as of May 9, 2025, as reported in the Issuer's Form 10-Q filed on May 13, 2025.
- Mr. Lytton holds sole voting and sole dispositive power over all 1,295,288 shares.
- The securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not convey positive or negative sentiment regarding the company's performance or prospects.
Positives
- NA
Negatives
- NA
Risks
- NA
Future Outlook
This document does not contain forward-looking statements or guidance regarding the company's future outlook.
Industry Context
This filing is a standard disclosure of beneficial ownership by an individual investor and does not provide broader industry context or trends.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant individual shareholder's stake and passive investment intent.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of event which requires filing of this statement |
| 05/09/2025 | Date as of which 49,817,835 shares of Common Stock were outstanding, as reported in the Issuer's Form 10-Q |
| 05/13/2025 | Date NeuroOne Medical Technologies Corp. filed its Form 10-Q |
| 05/15/2025 | Date of filing of this Schedule 13G Amendment No. 2 |
Keywords
NeuroOne Medical Technologies Corp., Schedule 13G, Beneficial Ownership, Common Stock, Laurence W. Lytton, SEC Filing, Warrants, Passive Investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.